Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Three Novel Alternative Splicing Mutations in BCR-ABL1 detected in CML Patients with Resistance to Kinase Inhibitors.

Wanlong Ma, Hagop Kantarjian, Jorge Cortes, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.

Blood (2009) 114 (22): 1107.

https://doi.org/10.1182/blood.V114.22.1107.1107

Published: 2009

Journal Articles

Clinical Relevance of Circulating Poly-Ubiquitin as a Prognostic Indicator in Chronic Lymphocytic Leukemia.

Wanlong Ma, Hagop M. Kantarjian, MD, Xiuqiang Wang, Susan O'Brien, Chen-Hsiung Yeh, XI Zhang, Zeev Estrov, MD, Anthony Sferruzza, PhD, William Weirda, Michael Keating, MD, Maher Albitar, MD

Blood (2009) 114 (22): 1240.

https://doi.org/10.1182/blood.V114.22.1240.1240

Published: 2009

Journal Articles

Use of Ubiquitin-Proteasome System Profiling for Differentiating Between Various Leukemic Processes.

Ke Zhang, Hagop M. Kantarjian, MD, Wanlong Ma, XI Zhang, Xiuqiang Wang, Zeev Estrov, MD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Michael Keating, MD, Maher Albitar, M.D.

Blood (2009) 114 (22): 4712.

https://doi.org/10.1182/blood.V114.22.4712.4712

Published: 2009

Journal Articles

Mutation and Single-Nucleotide Polymorphism (rs16754) in Wilms Tumor-1 Gene Are Independent Prognostic Factors in Acute Myeloid Leukemia.

Wanlong Ma, Hagop Kantarjian, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.

Blood (2009) 114 (22): 995.

https://doi.org/10.1182/blood.V114.22.995.995

Published: 2009

Journal Articles

Significant Association Between Promoter Polymorphism of the Erythropoietin Gene and Myelodysplastic Syndrome.

Wanlong Ma, Hagop Kantarjian, MD, Ke Zhang, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Elihu Estey, MD, Maher Albitar, M.D.

Blood (2009) 114 (22): 3825.

https://doi.org/10.1182/blood.V114.22.3825.3825

Published: 2009

Journal Articles

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia.

Jean-Marie Bruey, Hagop M. Kantarjian, MD, Zeev Estrov, MD, Wanlong Ma, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Maher Albitar, M.D.

Blood (2009) 114 (22): 4249.

https://doi.org/10.1182/blood.V114.22.4249.4249

Published: 2009

Journal Articles

MPL Mutation Profile in JAK2 Mutation-Negative Patients with Myeloproliferative Neoplasms.

Wanlong Ma, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Jennifer Uyeji, Maher Albitar, M.D.

Blood (2009) 114 (22): 1891.

https://doi.org/10.1182/blood.V114.22.1891.1891

Published: 2009

Journal Articles

Splice Variant JAK2 Transcript Deleting Exon 14 in Patients with Chronic Myeloproliferative Neoplasms.

Wanlong Ma, Hagop Kantarjian, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.

Blood (2009) 114 (22): 2161.

https://doi.org/10.1182/blood.V114.22.2161.2161

Published: 2009

Journal Articles

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Patients with Acute Myeloid Leukemia.

Jean-Marie Bruey, Hagop M. Kantarjian, MD, Zeev Estrov, MD, Wanlong Ma, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Elihu Estey, MD, Maher Albitar, M.D.

Blood (2009) 114 (22): 3104.

https://doi.org/10.1182/blood.V114.22.3104.3104

Published: 2009

Journal Articles

Performance Characteristics and Clinical Application of a Modified Thrombin Generation Assay.

Olga Zhukov, Joanna Popov, Mervyn Sahud, Anthony Sferruzza

Blood (2005) 106 (11): 4046.

https://doi.org/10.1182/blood.V106.11.4046.4046

Published: 2005

Journal Articles

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia

Dietmar Seiffert, Andrew M. Stern, William Ebling, Richard J. Rossi, Yu Chen Barrett, Richard Wynn, Gregory F. Hollis, Bokang He, Cathy J. Kieras, Donna L. Pedicord, Debra A. Cromley, Tsushung A. Hua, Robert B. Stein, Robert N. Daly, Anthony Sferruzza, Henry J. Pieniaszek, Jeffrey T. Billheimer

Blood (2003) 101 (1): 58–63.

https://doi.org/10.1182/blood-2002-02-0471

Published: 2003

NARROW

Three Novel Alternative Splicing Mutations in BCR-ABL1 detected in CML Patients with Resistance to Kinase Inhibitors.

Clinical Relevance of Circulating Poly-Ubiquitin as a Prognostic Indicator in Chronic Lymphocytic Leukemia.

Use of Ubiquitin-Proteasome System Profiling for Differentiating Between Various Leukemic Processes.

Mutation and Single-Nucleotide Polymorphism (rs16754) in Wilms Tumor-1 Gene Are Independent Prognostic Factors in Acute Myeloid Leukemia.

Significant Association Between Promoter Polymorphism of the Erythropoietin Gene and Myelodysplastic Syndrome.

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia.

MPL Mutation Profile in JAK2 Mutation-Negative Patients with Myeloproliferative Neoplasms.

Splice Variant JAK2 Transcript Deleting Exon 14 in Patients with Chronic Myeloproliferative Neoplasms.

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Patients with Acute Myeloid Leukemia.

Performance Characteristics and Clinical Application of a Modified Thrombin Generation Assay.

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only